CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-28 | Kim Paul CFO and Treasurer | Sale | −10,299 | $33.62 | $346K | 215,553 |
| 2023-08-21 | Hsieh Ming Chief Executive Officer | Other disposition · Forward sale contract (obligation to sell) | −750,000 | 0 | ||
| 2023-08-21 | Hsieh Ming Chief Executive Officer | Other acquisition · Forward sale contract (obligation to sell) | +750,000 | 750,000 | ||
| 2023-08-17 | Xie Jian President and COO | Sale | −1,307 | $33.88 | $44K | 417,514 |
| 2023-08-17 | Kim Paul CFO and Treasurer | Sale | −491 | $33.88 | $17K | 227,159 |
| 2023-08-17 | Kim Paul CFO and Treasurer | Sale | −1,307 | $33.88 | $44K | 225,852 |
| 2023-08-17 | Gao Hanlin Chief Scientific Officer | Sale | −342 | $33.88 | $12K | 913,973 |
| 2023-08-03 | Xie Jian President and COO | Shares withheld for taxes | −6,198 | $40.08 | $248K | 418,821 |
| 2023-08-03 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −1,240 | $40.08 | $50K | 227,650 |
| 2023-08-01 | Xie Jian President and COO | Shares withheld for taxes | −775 | $38.83 | $30K | 425,019 |
| 2023-08-01 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −4,783 | $38.83 | $186K | 643,772 |
| 2023-07-30 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −76 | $38.63 | $3K | 914,315 |
| 2023-06-02 | Xie Jian President and COO | Sale | −1,433 | $40.30 | $58K | 425,794 |
| 2023-06-02 | Kim Paul CFO and Treasurer | Sale | −1,403 | $40.30 | $57K | 228,890 |
| 2023-06-02 | Gao Hanlin Chief Scientific Officer | Sale | −1,000 | $40.30 | $40K | 914,391 |
| 2023-05-18 | GROVES REGINA E Director | Grant or award · Stock Option (Right to Buy) | +6,759 | 6,759 | ||
| 2023-05-18 | Nohaile Michael Director | Grant or award | +2,529 | 6,529 | ||
| 2023-05-18 | Nohaile Michael Director | Grant or award · Stock Option (Right to Buy) | +3,380 | 3,380 | ||
| 2023-05-18 | Marsh Linda Director | Grant or award | +5,059 | 10,659 | ||
| 2023-05-17 | Xie Jian President and COO | Sale | −1,320 | $35.46 | $47K | 427,227 |
Page 15 of 15 · 300 trades